Device Trial Radar · NCT06103591
Controlled Arterial Protection to Ultimately Remove Embolic Material
Last checked: Nov 19, 2026Latest source record: Apr 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Dec 27, 2023
Primary completion
Sep 4, 2024
Study completion Oct 14, 2024
Sponsor
- Lead sponsor
- EmStop IncNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Bright Research Partners
- First posted
- Oct 27, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to demonstrate device feasibility, safety and investigate performance of the EmStop Embolic Protection System when used as indicated in 15 subjects at 2 investigational sites in the U.S.
Conditions
- Aortic Valve Stenosis
Interventions
The EmStop Embolic Protection System (EmStop System)Device
The EmStop Embolic Protection System (EmStop System) is a catheter-based filter system that captures and removes debris dislodged during transcatheter aortic valve replacement (TAVR) procedures.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Procedural SuccessTime frame: During the procedure
- Occurrence of Major Adverse Cardiac and Cerebrovascular Events (MACCE) at 30 DaysTime frame: 30 days follow-up
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Mission Health
Asheville, North Carolina
Centennial Medical Center
Nashville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.